We are live on ! Find out more
RCAMU

Rothschild & Co Asset Management US Portfolio holdings

AUM $6.58B
1-Year Est. Return 4.5%
This Fund
S&P 500
This Quarter Est. Return
+15.69%
1 Year Est. Return
-4.5%
3 Year Est. Return
+63.72%
5 Year Est. Return
+103.96%
10 Year Est. Return
AUM
$8.1B
AUM Growth
+$326M
Cap. Flow
-$624M
Cap. Flow %
-7.7%
Top 10 Hldgs %
17.5%
Holding
317
New
30
Increased
63
Reduced
172
Closed
46

Top Buys

Rank Stock Value
1
WFC icon
Wells Fargo
WFC
+$89.8M
2
LUV icon
Southwest Airlines
LUV
+$61.6M
3
TSN icon
Tyson Foods
TSN
+$53.1M
4
GPN icon
Global Payments
GPN
+$33.6M
5
EMR icon
Emerson Electric
EMR
+$28.9M

Sector Composition

Rank Sector Weight
1 Financials 19.4%
2 Industrials 17.82%
3 Healthcare 14.96%
4 Consumer Discretionary 9.91%
5 Technology 8.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPHI
176
DELISTED
INPHI CORPORATION
IPHI
$12.3M 0.15%
68,964
-31,045
-31% -$5.19M
ESTC icon
177
Elastic
ESTC
$7.94B
$12.2M 0.15%
109,960
-49,500
-31% -$7.03M
DOOR
178
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$12M 0.15%
103,896
+9,952
+11% +$1.08M
SAIA icon
179
Saia
SAIA
$9.52B
$11.9M 0.15%
51,537
-12,222
-19% -$2.49M
ARNA
180
DELISTED
Arena Pharmaceuticals Inc
ARNA
$11.5M 0.14%
165,768
-48,529
-23% -$3.73M
MTZ icon
181
MasTec
MTZ
$21.9B
$11.4M 0.14%
121,885
-29,379
-19% -$2.51M
SPXC icon
182
SPX Corp
SPXC
$10.9B
$11.4M 0.14%
195,657
-254,109
-56% -$14.5M
FOLD
183
DELISTED
Amicus Therapeutics
FOLD
$11.3M 0.14%
1,145,594
-336,873
-23% -$5.21M
PTGX icon
184
Protagonist Therapeutics
PTGX
$9.6B
$11.2M 0.14%
+434,249
New +$11M
MMSI icon
185
Merit Medical Systems
MMSI
$5.44B
$11.2M 0.14%
187,048
-84,471
-31% -$4.84M
ACHC icon
186
Acadia Healthcare
ACHC
$2.9B
$11.1M 0.14%
194,677
-56,697
-23% -$3.07M
AMED
187
DELISTED
Amedisys
AMED
$11M 0.14%
41,413
-18,632
-31% -$5.25M
RVNC
188
DELISTED
Revance Therapeutics, Inc.
RVNC
$10.7M 0.13%
383,828
-46,008
-11% -$1.27M
WSFS icon
189
WSFS Financial
WSFS
$4.14B
$10.7M 0.13%
215,031
-491,471
-70% -$23.7M
ABT icon
190
Abbott
ABT
$190B
$10.6M 0.13%
88,228
-3,817
-4% -$452K
MA icon
191
Mastercard
MA
$492B
$10.4M 0.13%
29,232
-124
-0.4% -$43.3K
NBIX icon
192
Neurocrine Biosciences
NBIX
$16.5B
$10.4M 0.13%
106,538
-48,152
-31% -$5.05M
GTM
193
ZoomInfo Technologies
GTM
$1.19B
$9.99M 0.12%
+204,333
New +$10.3M
ATRC icon
194
AtriCure
ATRC
$2.18B
$9.79M 0.12%
149,458
-19,373
-11% -$1.19M
PETQ
195
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$9.67M 0.12%
274,362
+34,914
+15% +$1.24M
ASIX icon
196
AdvanSix
ASIX
$452M
$9.51M 0.12%
354,693
-27,194
-7% -$694K
LIVN icon
197
LivaNova
LIVN
$4.33B
$9.22M 0.11%
125,016
-14,742
-11% -$1.05M
MEDP icon
198
Medpace
MEDP
$16.9B
$9.15M 0.11%
55,759
-7,172
-11% -$1.1M
WW
199
DELISTED
WW International
WW
$9.11M 0.11%
+291,149
New +$8.39M
NXRT
200
NexPoint Residential Trust
NXRT
$631M
$9.05M 0.11%
196,387
-22,753
-10% -$975K

Similar funds

Rothschild & Co Asset Management US's Q1 2021 Portfolio in Review

As of Q1 2021, Rothschild & Co Asset Management US held 317 positions worth $8.1B, up 4.2% from $7.78B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Rothschild & Co Asset Management US withdrew a net $624M in Q1 2021, closing 46 positions and reducing 172 holdings. Its most notable exit was Willis Towers Watson, an estimated $77.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Rothschild & Co Asset Management US opened a new position in Wells Fargo worth $99.1M.

  • Rothschild & Co Asset Management US's largest Q1 2021 buy was Wells Fargo: 2,537,629 shares worth $99.1M.
  • Rothschild & Co Asset Management US added most to Global Payments in Q1 2021, an estimated $33.6M increase.
  • Rothschild & Co Asset Management US's biggest Q1 2021 reduction was Pultegroup, cutting an estimated $47.8M.
  • Rothschild & Co Asset Management US fully exited Willis Towers Watson in Q1 2021, selling an estimated $77.5M.
  • Rothschild & Co Asset Management US's ten largest holdings make up 18% of its $8.1B portfolio in Q1 2021.
  • Rothschild & Co Asset Management US opened 30 new positions and closed 46 in Q1 2021.
  • Rothschild & Co Asset Management US's portfolio value rose 4.2% quarter-over-quarter to $8.1B.

Based on Rothschild & Co Asset Management US's 13F filing for Q1 2021, filed 14 May 2021.